DOUG vs HUMA
Comparison between Douglas Elliman Inc (DOUG, Company) and Humacyte Inc (HUMA, Company).
DOUG is from the Real Estate sector, while HUMA is from the Healthcare sector.
5-Year PerformanceDOUG has outperformed HUMA, delivering a return of -32.2% compared to -42.5%
DOUG vs HUMA - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
DOUG vs HUMA - Historical Returns
Returns include dividend reinvestment.
DOUG vs HUMA - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | DOUG | HUMA |
|---|---|---|
| 2026 | -21.49% | -27.22% |
| 2025 | +45.40% | -81.46% |
| 2024 | -42.61% | +74.74% |
| 2023 | -23.85% | +34.60% |
| 2022 | -61.06% | -71.49% |
| 2021 | -5.19% | -33.85% |
DOUG vs HUMA Drawdown Comparison
The maximum drawdown for DOUG was -90.25%, occurring on Jun 17, 2024. This drawdown has not yet recovered.
The maximum drawdown for HUMA was -96.62%, occurring on Mar 30, 2026. This drawdown has not yet recovered.
The current DOUG drawdown is -83.23%. The current HUMA drawdown is -95.82%.
| Rank | DOUG | HUMA |
|---|---|---|
| #1 | -90.25% Dec 30, 2021 - Jun 17, 2024 | -96.62% Sep 1, 2021 - Mar 30, 2026 |
Correlation
Correlation between DOUG and HUMA is 0.40 which considered as a weak positive correlation - the stocks show a slight tendency to move together.
Select Stocks to Compare
More Comparisons
Compare with similar stocks